By Scientia Professor Matthew Colm Kiernan

Journal articles

Boland R; Lin CS-Y; Engel S; Kiernan MC, 2011, 'Adaptation of motor function after spinal cord injury: novel insights into spinal shock', Brain, 134, pp. 495 - 505, http://dx.doi.org/10.1093/brain/awq289

Boland R; Lin CS-Y; Engel S; Kiernan MC, 2011, 'Adaption of motor function after spinal cord injury: Novel insights into spinal shock', Brain, 134, pp. 495 - 505, http://dx.doi.org/10.1093/brain/awq289

Kiernan MC; Vucic S; Cheah BC; Turner MR; Eisen A; Hardiman O; Burrell JR; Zoing MC, 2011, 'Amyotrophic lateral sclerosis', Lancet, 377, pp. 942 - 955, http://dx.doi.org/10.1016/S0140-6736(10)61156-7

Kiernan MC; Steve V, 2011, 'Clarifying variability of corticomotoneuronal function in kennedy disease', Muscle and Nerve, 44, pp. 197 - 201, http://dx.doi.org/10.1002/mus.22017

Hardiman O; Van den berg L; Kiernan MC, 2011, 'Clinical diagnosis and management of amyotrophic lateral sclerosis', Nature Reviews Neurology, 7, pp. 639 - 649, http://dx.doi.org/10.1038/nrneurol.2011.153

Vucic O; Cheah BC; Yiannikas C; Kiernan MC, 2011, 'Cortical excitability distinguishes ALS from mimic disorders', Clinical Neurophysiology, 122, pp. 1860 - 1866, http://dx.doi.org/10.1016/j.clinph.2010.12.062

Vucic S; Cheah BC; Kiernan MC, 2011, 'Dissecting the Mechanisms Underlying Short-Interval Intracortical Inhibition Using Exercise', Cerebral Cortex, 21, pp. 1639 - 1644, http://dx.doi.org/10.1093/cercor/bhq235

Park SB; Lin CS-Y; Krishnan AV; Goldstein D; Friedlander M; Kiernan MC, 2011, 'Dose effects of Oxaliplatin on persistent and transient na+ conductances and the development of neurotoxicity', PLoS One, 6, pp. 1 - 7, http://dx.doi.org/10.1371/journal.pone.0018469

Farrar M; Vucic O; Lin CS-Y; Park SB; Johnston H; Bostock H; Kiernan MC, 2011, 'Dysfunction of axonal membrane conductances in adolescents and young adults with spinal muscular atrophy', Brain, 134, pp. 3185 - 3197, http://dx.doi.org/10.1093/brain/awr229

Park SB; Lin CS-Y; Krishnan AV; Friedlander M; Lewis C; Kiernan MC, 2011, 'Early Progressive and Sustained Dysfunction of Sensory Axons Underlies Paclitaxel-induced Neuropathy', Muscle and Nerve, 43, pp. 367 - 374, http://dx.doi.org/10.1002/mus.21874

Kiernan MC, 2011, 'Freud, Neurology and the Emergence of Dynamic Neural Networks', Journal of Neurology Neurosurgery and Psychiatry, 82, pp. 120 - 120, http://dx.doi.org/10.1136/jnnp.2010.224998

Lillo P; Mioshi E; Zoing M; Kiernan MC; Hodges JR, 2011, 'How common are behavioural changes in amyotrophic lateral sclerosis?', Amyotrophic Lateral Sclerosis, 12, pp. 45 - 51, http://dx.doi.org/10.3109/17482968.2010.520718

Burrell JR; Vucic S; Kiernan MC, 2011, 'Isolated bulbar phenotype of amyotrophic lateral sclerosis', Amyotrophic Lateral Sclerosis: Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases, 12, pp. 283 - 289, http://dx.doi.org/10.3109/17482968.2011.551940

Park SB; Lin CS-Y; Krishnan AV; Goldstein D; Friedlander M; Kiernan MC, 2011, 'Long-term neuropathy after Oxaliplatin treatment: Challenging the dictum of reversibility', Oncologist, 16, pp. 708 - 716, http://dx.doi.org/10.1634/theoncologist.2010-0248

Vucic S; Cheah BC; Kiernan MC, 2011, 'Maladaptation of cortical circuits underlies fatigue and weakness in ALS.', Amyotrophic Lateral Sclerosis, 12, pp. 414 - 420, http://dx.doi.org/10.3109/17482968.2011.597403

Burrell JR; Kiernan MC; Vucic S; Hodges JR, 2011, 'Motor neuron dysfunction in frontotemporal dementia', Brain: A Journal of Neurology, 134, pp. 2582 - 2594, http://dx.doi.org/10.1093/brain/awr195

Zoing M; Kiernan MC, 2011, 'Motor neurone disease Caring for the patient in general practice', Australian Family Physician, 40, pp. 962 - 966, http://search.informit.com.au/documentSummary;dn=686583020346040;res=IELHEA

Han SE; Lin CS-Y; Boland RA; Kiernan MC; Boland R, 2011, 'Nerve compression, membrane excitability, and symptoms of carpal tunnel syndrome', Muscle and Nerve, 44, pp. 402 - 409, http://dx.doi.org/10.1002/mus.22078

Huynh W; Kiernan MC, 2011, 'Nerve conduction studies', Australian Family Physician, 40, pp. 693 - 697

Cheah BC; Vucic S; Krishnan AV; Boland R; Kiernan MC, 2011, 'Neurophysiological index as a biomarker for ALS progression: Validity of mixed effects models', Amyotrophic Lateral Sclerosis, 12, pp. 33 - 38, http://dx.doi.org/10.3109/17482968.2010.531742

Burrell JR; Yiannikas C; Rowe D; Kiernan MC, 2011, 'Predicting a positive response to intravenous immunoglobulin in isolated lower motor neuron syndromes', PloS One, 6, pp. e27041 - e27041, http://dx.doi.org/10.1371/journal.pone.0027041

Lin CS-Y; Lee M; Park SB; Kiernan MC, 2011, 'Purple pigments: the pathophysiology of acute porphyric neuropathy', Clinical Neurophysiology, 122, pp. 2336 - 2344, http://dx.doi.org/10.1016/j.clinph.2011.07.036

Krishnan AV; Park SB; Payne ; Lin C; Vucic S; Kiernan MC, 2011, 'Regional differences in ulnar nerve excitability may predispose to the development of entrapment neuropathy', Clinical Neurophysiology, 122, pp. 194 - 198, http://dx.doi.org/10.1016/j.clinph.2010.04.038

Park SB; Lin CS-Y; Krishnan AV; Kiernan MC, 2011, 'The contribution of SK3 polymorphisms to acute oxaliplatin-induced neurotoxicity: direct or indirect effects?', Cancer Chemotherapy and Pharmacology, 67, pp. 1189 - 1190, http://dx.doi.org/10.1007/s00280-011-1579-y

Huynh W; Krishnan AV; Lin CS-Y; Vucic S; Kiernan MC, 2011, 'The effects of large artery ischemia and subsequent recanalization on nerve excitability', Muscle and Nerve, 44, pp. 841 - 841, http://dx.doi.org/10.1002/mus.22209

Kiernan MC, 2011, 'The Realm of Neurology – Past, Present and Future', Journal of Neurology Neurosurgery and Psychiatry, 82, pp. 1 - 1, http://dx.doi.org/10.1136/jnnp.2010.234344

Park SB; Lin CS-Y; Krishnan AV; Goldstein D; Friedlander M; Kiernan MC, 2011, 'Utilizing natural activity to dissect the pathophysiology of acute oxaliplatin-induced neuropathy', Experimental Neurology, 227, pp. 120 - 127, http://dx.doi.org/10.1016/j.expneurol.2010.10.002

Carson A; Kiernan MC, 2011, 'Who is really the world's best known neurologist?', Practical Neurology, 11, pp. 380 - 381, http://dx.doi.org/10.1136/practneurol-2011-000141

Arnold R; Pianta T; Pussell B; Grinius V; Lin C; Kiernan M; Jardine M; Krishnan A, 2010, 'DIFFERENTIAL EFFECTS OF HAEMODIAFILTRATION ON HIGH FLUX HAEMODIALYSIS ON NERVE FUNCTION IN VITRO', NEPHROLOGY, 15, pp. 86 - 86, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700227&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kiernan MF; Barrie A; Szkolar J; Mills TA; Wareing M, 2010, 'Functional Evidence for Oxygen-Sensitive Voltage-Gated Potassium Channels in Human Placental Vasculature', PLACENTA, 31, pp. 553 - 555, http://dx.doi.org/10.1016/j.placenta.2010.03.009

Talman PS; Kiernan M; Rowe D; Henderson R; Edis R; Thyagarajan D; Mathers S; Mcombe P, 2010, '13. Australian motor neuron disease registry 5 year follow-up', Journal of Clinical Neuroscience, 17, pp. 1613 - 1614, http://dx.doi.org/10.1016/j.jocn.2010.07.014

Vucic S; Cheah BC; Kiernan MC, 2010, '14. Central mechanisms underlying fatigue in amyotrophic lateral sclerosis', Journal of Clinical Neuroscience, 17, pp. 1614 - 1614, http://dx.doi.org/10.1016/j.jocn.2010.07.015

Burrell JR; Vucic S; Kiernan MC, 2010, '15. Distinct, isolated bulbar palsy presentations of amyotrophic lateral sclerosis', Journal of Clinical Neuroscience, 17, pp. 1614 - 1614, http://dx.doi.org/10.1016/j.jocn.2010.07.016

Huynh W; Lam A; Cheah B; Vucic S; Kiernan MC, 2010, '2. Corticospinal dysfunction and the development of amyotrophic lateral sclerosis following electrical injury', Clinical Neurophysiology, 121, pp. e1 - e1, http://dx.doi.org/10.1016/j.clinph.2009.10.022

Tomlinson SE; Grinton BE; Bostock H; Hanna MG; Kiernan MC; Berkovic SF; Burke D; Scheffer IE, 2010, '35. Peripheral nerve excitability testing shows distinctive ion channel dysfunction in patients with KCNQ2 mutations and epilepsy', Journal of Clinical Neuroscience, 17, pp. 1621 - 1621, http://dx.doi.org/10.1016/j.jocn.2010.07.036

Park SB; Lin CS-Y; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2010, '5. A novel biomarker of axonal dysfunction in oxaliplatin-induced neurotoxicity', Clinical Neurophysiology, 121, pp. e2 - e2, http://dx.doi.org/10.1016/j.clinph.2009.10.025

Farrar MA; Lin CS-Y; Krishnan A; Park SB; Andrews PI; Kiernan MC, 2010, '6. Axonal energy failure during a stroke-like episode in MELAS', Clinical Neurophysiology, 121, pp. e2 - e2, http://dx.doi.org/10.1016/j.clinph.2009.10.026

Farrar M; Lin CS-Y; Krishnan AV; Park SB; Andrews PI; Kiernan MC, 2010, 'Acute, reversible axonal energy failure during stroke-like episodes in MELAS', Pediatrics, 126, pp. e734 - e739

Han SH; Lin CS-Y; Boland R; Bilston LE; Kiernan MC, 2010, 'Changes in human sensory axonal excitability induced by focal nerve compression', The Journal of Physiology, 588, pp. 1737 - 1745

Vucic O; Nicholson GA; Kiernan MC, 2010, 'Cortical excitability in hereditary motor neuronopathy with pyramidal signs: comparison with ALS', Journal of Neurology Neurosurgery and Psychiatry, 81, pp. 97 - 100, http://jnnp.bmj.com/content/81/1/97.long

Vucic S; Cheah BC; Yiannikas C; Vincent A; Kiernan MC, 2010, 'Corticomotoneuronal function and hyperexcitability in acquired neuromyotonia', Brain, 133, pp. 2727 - 2733

Vucic O; Winhammar J; Rowe DB; Kiernan MC, 2010, 'Corticomotoneuronal function in asymptomatic SOD-1 mutation carriers', Clinical Neurophysiology, 121, pp. 1781 - 1785, http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VNP-4YRR0SH-3&_user=37161&_coverDate=04%2F01%2F2010&_alid=1345520628&_rdoc=1&_fmt=high&_orig=search&_cdi=6184&_sort=r&_docanchor=&view=c&_ct=1&_acct=C000004218&_version=1&_urlVersion=0&_userid=37161&md5=88e8298d87e96f53bf072614b1b6ae3b

Huynh W; Lam A; Vucic S; Cheah BC; Clouston P; Kiernan MC, 2010, 'Corticospinal tract dysfunction and development of Amyotrophic Lateral Sclerosis following electrical injury', Muscle and Nerve, 42, pp. 288 - 292, http://dx.doi.org/10.1002/mus.21681

Cheah B; Kiernan MC, 2010, 'Dexpramipexole, the R(+) enantiomer of pramipexole, for the potential treatment of amyotrophic lateral sclerosis', Idrugs, 13, pp. 911 - 920

Vucic O; Burke DJ; Kiernan MC, 2010, 'Fatigue in multiple sclerosis: Mechanisms and management', Clinical Neurophysiology, 121, pp. 809 - 817, http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VNP-4Y7P9VP-1&_user=37161&_coverDate=06%2F30%2F2010&_rdoc=1&_fmt=high&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000004218&_version=1&_urlVersion=0&_userid=37161&md5=6f9866fe6d6eea5f57f7571787fab98b

Blair IP; Williams KL; Warraich S; Durnall J; Theong A; Manavis J; Blumbergs PC; Vucic S; Kiernan MC; Nicholson GA, 2010, 'FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis', Journal of Neurology Neurosurgery and Psychiatry, 81, pp. 639 - 645, http://dx.doi.org/10.1136/jnnp.2009.194399

Cheah B; Kiernan MC, 2010, 'Neurophysiological methodolgies: Diagnosis of peripheral nerve disease and assessment of pharmacological agents', Current Opinion in Investigational Drugs, 11, pp. 72 - 79

Cheah B; Vucic O; Krishnan AV; Kiernan MC, 2010, 'Riluzole, Neuroprotection and Amyotrophic Lateral Sclerosis', Current Medicinal Chemistry: Cardiovascular and Hematological Agents, 17, pp. 1942 - 1959, http://www.benthamdirect.org/pages/content.php?CMC/2010/00000017/00000018/0006C.SGM

He EY; Wang L; Kiernan MC, 2010, 'Scurvy and stroke - is there an association?', Medical Journal of Australia, 193, pp. 555 - 556

Inam S; Vucic S; Brodaty NE; Zoing M; Kiernan MC, 2010, 'The 10-metre gait speed as a functional biomarker in amyotrophic lateral sclerosis', Amyotrophic Lateral Sclerosis, 11, pp. 558 - 561, http://dx.doi.org/10.3109/17482961003792958

Back to profile page